Table 1.

Cox proportional hazards regression models for overall survival and recurrence-free survival in OSCC patients.

	Overall survival			Recurrence-free survival
Characteristic	Hazard ratio	95% CI	p	Hazard ratio	95% CI	p
n = 100 OSCC patients
MCL-1 expression
Low	1			1
High	2.572	1.245–5.313	0.008**	2.323	1.153–4.679	0.015*
USP9X expression
Low	1			1
High	2.281	1.134–4.590	0.017*	2.05	1.041–4.039	0.034*
Lymph node
No	1			1
N+	2.639	1.211–5.749	0.015*	2.788	1.283–6.057	0.01*
Site of primary tumour
Tounge	1			1
Alveolus	2.478	0.971–6.321	0.058 ns	2.411	0.945–6.150	0.066 ns
Buccal mucosa	2.553	1.200–5.432	0.015*	2.659	1.257–5.625	0.011*
T stage
T1-T2	1			1
T3-T4	2.485	0.765–8.075	0.13	2.58	0.795–8.374	0.115 ns
Differentiation status
Moderate-well	1			1
Poor	1.774	0.936–3.360	0.079	1.936	1.033–3.626	0.039*
Combination MCL-1/USP9X
Any low MCL-1/USP9X	1			1
Both MCL-1/USP9X High	3.241	1.543–5.657	0.005**	3.022	1.451–5.193	0.011*

p > 0.05 ns not significant.

*p < 0.05.

**p < 0.01.